|
Back to Blog
Collapsible metal tubes are lightweight, compressible, and sealable containers used to package viscous substances such as pharmaceutical products, cosmetics, and food. They provide benefits such as ease of application, precise dosing, product protection, and long shelf life. Utilizing a squeezable and reclosable design, collapsible metal tubes offer consumers hygienic and mess-free usage. The need for compact and portable packaging for on-the-go consumption has been boosting the demand for collapsible metal tubes.
The Global Collapsible Metal Tubes Market Demand is estimated to be valued at US$ 11.76 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Collapsible Metal Tubes market are PPG Industries, Akzo Nobel N.V., Sherwin-Williams Company, BASF SE, The Dow Chemical Company, Arkema Group, RPM International Inc., Nippon Paint Holdings Co., Ltd., Axalta Coating Systems Ltd., Asian Paints Limited, Kansai Paint Co., Ltd., Jotun Group, Sika AG, Hempel A/S, Benjamin Moore & Co. These players maintain a competitive edge in the market by adopting strategies such as mergers, acquisitions, partnerships, and new product development. The increasing demand for on-the-go consumption of personal care and cosmetic products presents significant opportunities for players in the collapsible metal tubes market. Manufacturers are focused on development of innovative packaging formats that enhance portability and convenience. North America and Europe collectively account for over 50% share of the global collapsible metal tubes market. However, expanding middle-class population and rising disposable incomes in Asia Pacific are likely to drive market growth in the region during the forecast period. Key players are emphasizing strategic expansion into high-potential emerging markets to gain market share. Market Drivers Convenient packaging format - Collapsible metal tubes offer convenient packaging solutions for viscous products that need to be squeezed out of the package. Their squeezable and re-closable design provides easier application and transportation. Growth of cosmetics and personal care industry - Expanding consumption of cosmetic products such as facial creams, hair styling gels, and deodorants is propelling the demand for convenient packaging solutions such as collapsible metal tubes. Market Restraints High production costs - Metal tube making requires expensive machinery which increases the costs. This hinders market growth, especially in price-sensitive regions. Growing environmental concerns - Disposal of used metal tubes generates waste that takes long to decompose. Stringent environmental regulations regarding non-recyclable packaging pose challenges to market players. Segment Analysis The sub segment of collapsible metal tubes with capacity below 50 ml is dominating the market as these tubes are used for small quantity packaging of cosmetic and healthcare products like toothpaste, ointments, creams etc. where precise dispensing and minimum wastage is required. These tubes provide good barrier protection, are lightweight and have superior shelf life which makes them a preferred choice for small quantity packaging. The pharmaceutical sub segment holds a major share due to increasing usage of collapsible metal tubes for oral liquid formulations, eye & ear drops and dental pastes. Factors like portability, ease of use, precision in dosages and product safety have increased the adoption of collapsible metal tubes in the pharmaceutical industry. Global Analysis The Asia Pacific region is forecasted to be the fastest growing as well as dominating region in the collapsible metal tubes market during the forecast period. Factors such as rising disposable incomes, growth in middle class population India and China will drive the demand for cosmetic and personal care products which in turn increases the usage of collapsible metal tubes in these industries. North America and Europe are also significant markets however the growth rates are expected to be lower than the Asia Pacific region due to market maturity. Key players like PPG Industries, Akzo Nobel N.V., and The Sherwin-Williams Company are focusing on expanding their presence in emerging countries of Asia Pacific through partnerships and new product launches. Get more insights on The Global Collapsible MetalTubes Market
0 Comments
Read More
Back to Blog
Clinical data management involves the planning, collection, quality control and storage of data generated during clinical trials or research. It plays a pivotal role in maintaining integrity, compliance and improving efficiency of clinical research. The clinical data management process helps in compliance with regulatory standards and protocols. It offers advantages such as electronic data capture, data standardization and improved accessibility of data. With rising complexity of clinical trials and increasing investments in pharmaceutical R&D, demand for efficient data management systems has been gaining traction.
The Global Clinical Data Management Market Demand is estimated to be valued at US$ 32.33 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Clinical Data Management Market are FedEx (Federal Express) Corporation, United Parcel Service Inc., The Emirates Group, Japan Airlines Co. Ltd and All Nippon Airways Co. Ltd (ANA). Clinical data management offers several opportunities for players including scope for partnerships, data integration solutions and real-time data analysis tools. With growing clinical trials in emerging markets and focus on data privacy, players are likely to expand globally in the upcoming years. Key opportunities in the market include growing adoption of electronic data capture systems in clinical trials, integration of AI and blockchain technology for improved data quality and focus on data standardization. The market is witnessing increased globalization with large pharmaceutical companies outsourcing data management operations to CROs globally. Market drivers Rising focus on improving patient safety and data integrity standards set by regulatory bodies is a key driver for the clinical data management market. Stringent regulations related to data privacy and security are also propelling organizations to invest in validated and optimized data management solutions. Growing R&D expenditure of pharmaceutical companies and expansion of clinical trial operations to emerging countries further supports the market growth. PEST Analysis Political: The Clinical Data Management Market is regulated by the regulatory bodies like the US FDA and EMA. They set rules and standards for data collection, storage and security which impacts operations. Economic: Economic growth is driving investments in healthcare and clinical research. Higher disposable incomes have increased demand for efficient data management solutions to accelerate clinical trials. Social: Increase in lifestyle diseases, aging population and focus on personalized medicines is driving clinical trials. Consumers want faster access to new treatments fueling demand for improved data management. Technological: Technologies like AI, cloud, analytics are being used to simplify data collection and integrate isolated systems. Automation is helping improve efficiency and reduce trial costs and timelines. The geographical region where the Clinical Data Management Market value is highly concentrated is North America. It accounts for the largest share due to presence of major pharmaceutical companies, high healthcare expenditures and stringent regulatory guidelines for data management. The fastest growing region for the Clinical Data Management Market is Asia Pacific. Growing clinical research outsourcing to low-cost destinations like China and India coupled with increased emphasis on R&D by governments is fueling market growth in Asia Pacific. Get more insights on Clinical DataManagement Market
Back to Blog
The global cannabis extract market is a rapidly evolving space, gaining traction across North America and Europe. Cannabis extracts provide several therapeutic benefits and find wide applications in pharmaceuticals, food & beverages, personal care products, and others. Cannabis extracts contain high concentrations of cannabinoids like THC and CBD and offer advantages like consistency of dosage and ease of ingestion over naturally growing cannabis. With more countries legalizing medical and recreational use of cannabis, the demand for high-quality cannabis extracts is witnessing a solid rise.
Cannabis extracts are processed using advanced techniques like solvent extraction, supercritical fluid extraction, short path evaporators, and chromatography to derive concentrates high in targeted cannabinoids and other compounds. These premium quality extracts appeal to health-conscious consumers relying on cannabis therapy for conditions like chronic pain, mental health issues, cancer, epilepsy, and more. Growing prevalence of such ailments along with surging aging population susceptible to various illnesses is fueling the incorporation of extracts in wellness products. The Global cannabis extract market is estimated to be valued at US$ 12331.66 Bn in 2024 and is expected to exhibit a CAGR of 23.% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Cannabis Extract Market Demand are Zeta Global Corp, Oracle Corporation, mParticle Inc., Salesforce.com Inc., BlueConic, Adobe Inc., Tealium, SAP SE, Acquia Inc., and Segment.Io Inc. (Twilio). These leading brands are focusing on new product innovations, aggressive marketing strategies, and strategic collaborations to strengthen their market presence. The legal cannabis industry offers massive opportunities for players across the value chain to serve the growing consumer demand. Cultivators, manufacturers, and retailers are investing heavily to set up Licensed Producer facilities, sophisticated extraction labs, and modern dispensaries. This is helping facilitate safe and regulated supply of extracts. Major players are scouting attractive international markets and forging licensing agreements to augment sales from European, Asian, and Latin American countries gradually weed legalization. Companies are also undertaking mergers and acquisitions to broaden their geographic coverage and product portfolio to leverage lucrative expansion avenues on a global scale. Market Drivers - Increasing legalization of cannabis for medical use across regions like North America, Europe, and Asia Pacific is a key market driver as it encourages more funding in research and commercial production of extracts. - Growing consumer awareness about various medical benefits of specific cannabinoids is propelling the popularity of extracts standardized for THC or CBD content. Market Restraints - Usage of extraction solvents like ethanol, butane, and propane poses safety hazards if not handled carefully which is a challenge for extract manufacturers. - Legal restrictions in many countries hamper the proliferation of extracts containing high psychoactive THC levels. This limits business scopes for some market players. Segment Analysis The Cannabis Extract market can be segmented based on product into cannabis concentrates and cannabis infused products. Cannabis concentrates dominate the market as they provide concentrated forms of cannabinoids like THC and CBD. Cannabis concentrates include hashish, hash oil, kief, rosin and others. They offer a more potent effect as compared to traditional cannabis and are preferred by consumers and medical users who want a precise dosage. Global Analysis Regionally, North America dominates the Cannabis Extract market due to legalization of cannabis in major countries like United States and Canada. According to estimates, the North American market was valued at US$ 3,700 Mn in 2020. The region will continue to be the largest market during the forecast period due to growing product adoption for medical as well as recreational purposes in the region. Europe is the second largest market and is expected to witness strong growth during 2024-2031. Countries like Germany, Italy, Netherlands and Switzerland have legalized cannabis for medical use which is driving the market in the region. Asia Pacific is projected to be the fastest growing market due to increasing social acceptance of cannabis combined with initiatives by regional governments to legalize it for medical purposes in countries like Australia, Thailand and South Korea. Get more insights on Cannabis Extract Market
Back to Blog
Market Overview
|